Dr. Ian Rabinowitz
Claim this profileUniversity of New Mexico Cancer Center
Studies Skin Cancer
Studies Cutaneous Melanoma
7 reported clinical trials
16 drugs studied
Area of expertise
1Skin Cancer
Stage IV
BRAF positive
Stage III
2Cutaneous Melanoma
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Ian Rabinowitz is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Ian Rabinowitz
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Ian Rabinowitz has experience with
- Nivolumab
- Ipilimumab
- Biospecimen Collection
- Crizotinib
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
Breakdown of trials Ian Rabinowitz has run
Skin Cancer
Cutaneous Melanoma
Melanoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ian Rabinowitz specialize in?
Ian Rabinowitz focuses on Skin Cancer and Cutaneous Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Ian Rabinowitz currently recruiting for clinical trials?
Yes, Ian Rabinowitz is currently recruiting for 5 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Ian Rabinowitz has studied deeply?
Yes, Ian Rabinowitz has studied treatments such as Nivolumab, Ipilimumab, Biospecimen Collection.
What is the best way to schedule an appointment with Ian Rabinowitz?
Apply for one of the trials that Ian Rabinowitz is conducting.
What is the office address of Ian Rabinowitz?
The office of Ian Rabinowitz is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.